TrialAmerican journal of hematology2026

Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

Teresa Bernal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.